Guardant Health Analysts Lift Targets Before Q3 Print
GH gained 9.5% last week to $178.06, outpacing a peer median of 2.9%, with the move pulling the stock to within 12% of the consensus price target of $202.24. Short interest at 8.8% of the free float is meaningful but…
